Posted on March 17, 2022
Moderna's announced plans to manufacture COVID-19 vaccines in Kenya. The pharmaceutical company holds much of the key intellectual property relating to mRNA vaccines, which are preferred in developed nations due to their better efficacy rates. University of Pretoria technology
Full Interview: Moderna's announced plans to manufacture COVID-19 vaccines in Kenya
Copyright © University of Pretoria 2024. All rights reserved.
Virtual Campus
Get Social With Us
Download the UP Mobile App